These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11547494)

  • 1. Research sheds light on treatment interruption.
    Fauci A
    AIDS Alert; 2001 Sep; 16(9):114-6. PubMed ID: 11547494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection.
    Cardiello PG; Hassink E; Ananworanich J; Srasuebkul P; Samor T; Mahanontharit A; Ruxrungtham K; Hirschel B; Lange J; Phanuphak P; Cooper DA
    Clin Infect Dis; 2005 Feb; 40(4):594-600. PubMed ID: 15712083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report from Buenos Aires: the 1st IAS Conference on HIV Pathogenesis and Treatment.
    Gallant JE
    Hopkins HIV Rep; 2001 Sep; 13(5):1-7, 15. PubMed ID: 11682857
    [No Abstract]   [Full Text] [Related]  

  • 4. What do the studies show about STIs in the chronically HIV-1 infected patient?
    Wilcox RD
    HIV Clin; 2006; 18(2):1-3. PubMed ID: 16941772
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunovirologic consequences and safety of short, non-structured interruptions of successful antiretroviral treatment.
    Sanchez R; Portilla J; Gimeno A; Boix V; Llopis C; Sanchez-Paya J; Merino E; de la Sen ML; Muñoz C; Reus S; Plazas J
    J Infect; 2007 Feb; 54(2):159-66. PubMed ID: 16690132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonnucleoside reverse transcriptase inhibitors.
    Murphy RL
    AIDS Clin Care; 1997 Oct; 9(10):75-7, 79. PubMed ID: 11364757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple nuke therapy--results after one year.
    TreatmentUpdate; 2001; 12(10):3-4. PubMed ID: 11570063
    [No Abstract]   [Full Text] [Related]  

  • 8. Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study.
    Boyd MA; Amin J; Mallon PW; Kumarasamy N; Lombaard J; Wood R; Chetchotisakd P; Phanuphak P; Mohapi L; Azwa I; Belloso WH; Molina JM; Hoy J; Moore CL; Emery S; Cooper DA;
    Lancet HIV; 2017 Jan; 4(1):e13-e20. PubMed ID: 27815068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HIV-infection: modern antiretroviral therapy].
    Rockstroh JK; Spengler U
    Dtsch Med Wochenschr; 2004 Sep; 129(37):1921-4. PubMed ID: 15372371
    [No Abstract]   [Full Text] [Related]  

  • 10. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
    Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
    Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-daily therapy--results after one year.
    TreatmentUpdate; 2001; 12(12):4-5. PubMed ID: 11570091
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiretroviral rounds. When success is a pain.
    Bartlett JG; del Rio C
    AIDS Clin Care; 2001 Aug; 13(8):74-5. PubMed ID: 11547461
    [No Abstract]   [Full Text] [Related]  

  • 13. Predictors of sustained response to therapy resumption after treatment interruption in HIV-infected patients failing antiretroviral therapy.
    Gianotti N; Soria A; Galli L; Castagna A; Cernuschi M; Hasson H; Lazzarin A
    J Med Virol; 2004 Feb; 72(2):181-6. PubMed ID: 14695657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 genotype after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and virological response after resumption of the same regimen.
    Sungkanuparph S; Kiertiburanakul S; Apisarnthanarak A; Malathum K; Sathapatayavongs B
    Int J STD AIDS; 2007 Dec; 18(12):832-4. PubMed ID: 18073016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI/NRTI "sparing" regimens for HIV infection. IAPAC sessions 2001, July 18-19, 2001 - Chicago.
    Cohen C
    IAPAC Mon; 2001 Aug; 7(8):254-60. PubMed ID: 11708281
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.
    Yeni PG; Hammer SM; Carpenter CC; Cooper DA; Fischl MA; Gatell JM; Gazzard BG; Hirsch MS; Jacobsen DM; Katzenstein DA; Montaner JS; Richman DD; Saag MS; Schechter M; Schooley RT; Thompson MA; Vella S; Volberding PA
    JAMA; 2002 Jul; 288(2):222-35. PubMed ID: 12095387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial comparing regimens of four reverse transcriptase inhibitors given together or cyclically in HIV-1 infection--the Quattro Trial. Quattro Steering Committee.
    AIDS; 1999 Nov; 13(16):2209-17. PubMed ID: 10563706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiretroviral therapy of HIV infections. New recommendations by the International AIDS Society].
    Allouch H
    Presse Med; 1998 Nov; 27(34):1739-41. PubMed ID: 9835934
    [No Abstract]   [Full Text] [Related]  

  • 19. Rescue me.
    Simmons P
    Res Initiat Treat Action; 1998 Aug; 4(5):10. PubMed ID: 11365705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV news from Buenos Aires: Part 2--symmetries and semistops.
    Mascolini M
    IAPAC Mon; 2001 Oct; 7(10):294-308. PubMed ID: 11785462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.